SUVOREXANT: TARGETING OREXIN TO AUGMENT EXPOSURE THERAPY IN VETERANS WITH PTSD AND INSOMNIA
$2,946,999FY2025Defense Health AgencyDOD
Northern California Institute For Research And Education, Inc.
Northern California Institute For Research And Education, Inc.